Evidence map›Paper›PMID 33294017›Full record

ArticleEvolutionary applications2020

Collagen production and niche engineering: A novel strategy for cancer cells to survive acidosis in DCIS and evolve.

Mehdi Damaghi, Hidetoshi Mori, Samantha Byrne, Liping Xu, Tingan Chen, Joseph Johnson, Nathan D Gallant, Andriy Marusyk, Alexander D Borowsky, Robert J Gillies

Open access · goldAbstract read
In one paragraph

Article in Evolutionary applications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. αSMAOncogene · 2021
    Article
  17. Proton Transport in Cancer Cells: The Role of Carbonic Anhydrases.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mehdi DamaghiDepartment of Cancer Physiology Moffitt Cancer Center and Research Institute Tampa FL USA.ORCID https://orcid.org/0000-0002-7744-6161
Hidetoshi MoriCenter for Immunology and Infectious Diseases Comprehensive Cancer Center Department of Pathology and Laboratory Medicine School of Medicine University of California, Davis Sacramento CA USA.
Samantha ByrneDepartment of Cancer Physiology Moffitt Cancer Center and Research Institute Tampa FL USA.
Liping XuDepartment of Cancer Physiology Moffitt Cancer Center and Research Institute Tampa FL USA.
Tingan ChenAnalytic Microscopy Core Moffitt Cancer Center and Research Institute Tampa FL USA.
Joseph JohnsonAnalytic Microscopy Core Moffitt Cancer Center and Research Institute Tampa FL USA.
Nathan D GallantDepartment of Mechanical Engineering University of South Florida Tampa FL USA.
Andriy MarusykDepartment of Cancer Physiology Moffitt Cancer Center and Research Institute Tampa FL USA.
Alexander D BorowskyCenter for Immunology and Infectious Diseases Comprehensive Cancer Center Department of Pathology and Laboratory Medicine School of Medicine University of California, Davis Sacramento CA USA.
Robert J GilliesDepartment of Cancer Physiology Moffitt Cancer Center and Research Institute Tampa FL USA.
Moffitt Cancer Center · USUniversity of California, Davis · USUniversity of South Florida · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
"Research Supplement to Promote Diversity in Health-Related Research", as part of Moffitt PS-OC, "Cancer as a Complex adaptive System"U54CA193489 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI ANDERSON, ALEXANDER ROBERTSON ALLAN, GATENBY, ROBERT A · 2015 to 2020
$12.5M
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancersU01CA196406 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOROWSKY, ALEXANDER D, ESSERMAN, LAURA J · 2015 to 2020
$5.8M
NCI NIH HHS P30 CA076292NCI NIH HHS U01 CA196406NCI NIH HHS U54 CA193489
6 · The paper itself

Abstract

Growing tumors are dynamic and nonlinear ecosystems, wherein cancer cells adapt to their local microenvironment, and these adaptations further modify the environment, inducing more changes. From nascent intraductal neoplasms to disseminated metastatic disease, several levels of evolutionary adaptations and selections occur. Here, we focus on one example of such an adaptation mechanism, namely, "niche construction" promoted by adaptation to acidosis, which is a metabolic adaptation to the early harsh environment in intraductal neoplasms. The avascular characteristics of ductal carcinoma in situ (DCIS) make the periluminal volume profoundly acidic, and cancer cells must adapt to this to survive. Based on discovery proteomics, we hypothesized that a component of acid adaptation involves production of collagen by pre-cancer cells that remodels the extracellular matrix (ECM) and stabilizes cells under acid stress. The proteomic data were surprising as collagen production and deposition are commonly believed to be the responsibility of mesenchymally derived fibroblasts, and not cells of epithelial origin. Subsequent experiments in 3D culture, spinning disk and second harmonic generation microscopy of DCIS lesions in patients' samples are concordant. Collagen production assay by acid-adapted cells in vitro demonstrated that the mechanism of induction involves the RAS and SMAD pathways. Secretome analyses show upregulation of ECM remodeling enzymes such as TGM2 and LOXL2 that are collagen crosslinkers. These data strongly indicate that acidosis in incipient cancers induces collagen production by cancer cells and support the hypothesis that this adaptation initiates a tumor-permissive microenvironment promoting survival and growth of nascent cancers.

Indexed as

anoikiscancer evolutioncollagen productionextracellular matrix remodeling enzymesK‐RASNiche construction and engineeringSMADtumor microenvironment

Identifiers

PMID33294017
PMCPMC7691473
OpenAlexW3045007677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.